Business

Weight Loss Drug Company Falters

Updated 2026-06-08 09:45 UTC 1 source Negative

The stock of a weight loss drug company fell by 25% after new safety data raised concerns among investors. Despite meeting key targets, analysts are worried about the commercial viability due to side effects.

Coverage timeline — 1 article

CNBC

Weight loss drug maker sinks 25% after new safety data spooks investors

While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.

2026-06-08 09:40 UTC